June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
An improved algorithm for the assessment of quantitative vitreous haze from fundus photographs
Author Affiliations & Notes
  • Karl Landheer
    Regeneron Pharmaceuticals, Inc, Tarrytown, New York, United States
  • Farshid Sepehrband
    Regeneron Pharmaceuticals, Inc, Tarrytown, New York, United States
  • Jonathan Weyne
    Regeneron Pharmaceuticals, Inc, Tarrytown, New York, United States
  • Karen Chu
    Regeneron Pharmaceuticals, Inc, Tarrytown, New York, United States
  • Stefanie Hectors
    Regeneron Pharmaceuticals, Inc, Tarrytown, New York, United States
  • Prodromos Parasoglou
    Regeneron Pharmaceuticals, Inc, Tarrytown, New York, United States
  • Nicholas Gale
    Regeneron Pharmaceuticals, Inc, Tarrytown, New York, United States
  • Andrew Murphy
    Regeneron Pharmaceuticals, Inc, Tarrytown, New York, United States
  • Johnathon Walls
    Regeneron Pharmaceuticals, Inc, Tarrytown, New York, United States
  • Mary Germino
    Regeneron Pharmaceuticals, Inc, Tarrytown, New York, United States
  • Footnotes
    Commercial Relationships   Karl Landheer Regeneron Pharmaceuticals, Inc, Code E (Employment), Regeneron Pharmaceuticals, Inc, Code I (Personal Financial Interest), Regeneron Pharmaceuticals, Inc, Code O (Owner); Farshid Sepehrband Regeneron Pharmaceuticals, Inc, Code E (Employment), Regeneron Pharmaceuticals, Inc, Code I (Personal Financial Interest), Regeneron Pharmaceuticals, Inc, Code O (Owner); Jonathan Weyne Regeneron Pharmaceuticals, Inc, Code E (Employment), Regeneron Pharmaceuticals, Inc, Code I (Personal Financial Interest), Regeneron Pharmaceuticals, Inc, Code O (Owner); Karen Chu Regeneron Pharmaceuticals, Inc, Code E (Employment), Regeneron Pharmaceuticals, Inc, Code I (Personal Financial Interest), Regeneron Pharmaceuticals, Inc, Code O (Owner); Stefanie Hectors Regeneron Pharmaceuticals, Inc, Code E (Employment), Regeneron Pharmaceuticals, Inc, Code I (Personal Financial Interest), Regeneron Pharmaceuticals, Inc, Code O (Owner); Prodromos Parasoglou Regeneron Pharmaceuticals, Inc, Code E (Employment), Regeneron Pharmaceuticals, Inc, Code I (Personal Financial Interest), Regeneron Pharmaceuticals, Inc, Code O (Owner); Nicholas Gale Regeneron Pharmaceuticals, Inc, Code E (Employment), Regeneron Pharmaceuticals, Inc, Code I (Personal Financial Interest), Regeneron Pharmaceuticals, Inc, Code O (Owner); Andrew Murphy Regeneron Pharmaceuticals, Inc, Code E (Employment), Regeneron Pharmaceuticals, Inc, Code I (Personal Financial Interest), Regeneron Pharmaceuticals, Inc, Code O (Owner); Johnathon Walls Regeneron Pharmaceuticals, Inc, Code E (Employment), Regeneron Pharmaceuticals, Inc, Code I (Personal Financial Interest), Regeneron Pharmaceuticals, Inc, Code O (Owner); Mary Germino Regeneron Pharmaceuticals, Inc, Code E (Employment), Regeneron Pharmaceuticals, Inc, Code I (Personal Financial Interest), Regeneron Pharmaceuticals, Inc, Code O (Owner)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 4109 – F0073. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Karl Landheer, Farshid Sepehrband, Jonathan Weyne, Karen Chu, Stefanie Hectors, Prodromos Parasoglou, Nicholas Gale, Andrew Murphy, Johnathon Walls, Mary Germino; An improved algorithm for the assessment of quantitative vitreous haze from fundus photographs. Invest. Ophthalmol. Vis. Sci. 2022;63(7):4109 – F0073.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To improve the quantification of vitreous haze (VH), a key clinical feature of uveitis, we modified the Passaglia quantitative vitreous algorithm (PQVHA). The PQVHA was developed to improve upon the Miami Scale, which utilizes color fundus photographs (CFP) graded by an expert reader rating the VH as an integer from 0 (no haze) to 8 (extreme haze). The PQVHA addresses important limitations of the Miami Scale: dependence on an expert reader, subjective grading and a categorical scoring system. Our modifications to the PQVHA aim to reduce its sensitivity to variability of image acquisition and quality.

Methods : The data was from a phase 2 randomized, double-masked and placebo-controlled study to evaluate the efficacy and safety of Sarilumab in 58 patients with Non-infectious, Intermediate, Posterior or Pan-Uveitis. Each of the 5 PQVHA steps were modified. 1) The green channel of the CFP had the most contrast so was used for analysis, rather than a grayscale conversion. The images were then histogram normalized and gamma corrected. 2) A Gaussian kernel was used as a high-pass filter instead of a rect function, as the latter provides non-monotonic sinc-weighting to spatial frequencies. 3) Local entropy was not used because it can provide extreme weighting to small artifacts. 4) The magnitude spectrum was used instead of the power spectrum, as the latter’s square function provides excessive weighting to a small number of high spatial frequencies. 5) The magnitude spectrum was integrated, and log transformed for a final value. Given the lack of ground truth to assess haze scores, the robustness of PQVHA and our algorithm were assessed by comparing the correlation of the scores with two expert readings in N=3245 images.

Results : The R2 between our algorithm values and raters 1 and 2 was 0.33 and 0.50, respectively. For comparison, the R2 between the values from the PQVHA and raters 1 and 2 were 0.10 and 0.08, respectively, and the R2 between rater 1 and rater 2 was 0.34.

Conclusions : Our method builds upon the PQVHA to increase robustness against the particular experimental conditions between subjects and time points common to clinical trials.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

A rank ordering of images across all images by haze score from the PQVHA, with PQVHA haze in the top left. The haze score does not correspond to the blur the image determined by inspection.

A rank ordering of images across all images by haze score from the PQVHA, with PQVHA haze in the top left. The haze score does not correspond to the blur the image determined by inspection.

 

A rank ordering of all images by haziness value from our modified algorithm.

A rank ordering of all images by haziness value from our modified algorithm.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×